Anti-Diabetic Effects of Ayanin, a Flavonoid Compound, in STZ/HFD-Induced Diabetic Mice by Upregulating GLUT4 and Suppressing Macrophage-Driven Inflammation in Adipose Tissues
Lv Y., Wu C., Yang W., Wang C., Huang J., Wang J.
Animal Study on Type 2 Diabetes, published in Food Sci Nutr (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Food Sci Nutr (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41509193
- PMCID
- PMC12778411
- DOI
- 10.1002/fsn3.71429
Abstract (original English)
Insulin resistance, marked by reduced GLUT4 expression in metabolic tissues such as adipose tissue and skeletal muscle, is a key contributor to the pathogenesis of Type 2 diabetes. Therapeutic agents that enhance GLUT4 expression in these tissues have demonstrated potential in the treatment of diabetes. Ayanin (AYN) is a flavonoid found in red wine grapes. This study evaluated the anti-diabetic properties of AYN and investigated its mechanisms. In an in vivo study, the oral administration of AYN to diabetic mice resulted in ameliorated hyperglycemia and glucose tolerance and alleviated lipid dysfunction. The investigation into the underlying mechanisms revealed that AYN activated p-AMPKα, which subsequently enhanced GLUT4 and CPT-1α expression in both adipose and muscle tissues, as well as increased CPT-1α expression in livers. In vitro experiments demonstrated that AYN activated AMPKα, increased GLUT4 expression, and facilitated glucose uptake in 3T3-L1 adipocytes. Additionally, the metabolic dysfunctions related to lipids and glucose in adipocytes triggered inflammatory activation of macrophages within adipose tissue, leading to the exacerbation of insulin resistance and the downregulation of GLUT4 expression. AYN reduced macrophage infiltration and pro-inflammatory mRNA expression in adipose tissues, contributing to the amelioration of diabetes. In vitro results for macropha
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review
Systematic Review on Type 2 Diabetes, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep2 citations - Level ASystematic ReviewEurope PMC
Dedifferentiation of Mature Adipocytes and Their Future Potential for Regenerative Medicine Applications
Systematic Review on Type 2 Diabetes, Chronic Wound, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level ASystematic ReviewEurope PMC
Consolidating Clinical Insights and Uncovering Novel Regulatory Mechanisms of Exosomal MicroRNAs in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Review and Bioinformatics Analysis
Systematic Review on Type 2 Diabetes, Chronic Inflammation, published in Food Sci Nutr (2026) — summary generated from the PubMed abstract.
- 2026
Food Sci Nutr - Level AMeta-analysisEurope PMC
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Meta-analysis on Type 2 Diabetes, Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells1 citations - Level ASystematic ReviewPubMed
Systematic Review: Exosomes as Molecular Messengers in the Development of Obesity-Related Complications in Children.
Systematic Review on Type 2 Diabetes, published in Curr Issues Mol Biol (2025) — summary generated from the PubMed abstract.
- 2025
Curr Issues Mol Biol - Level AMeta-analysisEurope PMC
Thiamine as a putative natural modulator of PPARγ: exploring a nutrient-based approach for type 2 diabetes
Meta-analysis on Type 2 Diabetes, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol